The global retractable needle safety syringes market is likely to reach a valuation of USD 5,846.6 million in 2023 and is projected to expand at a steady CAGR of 4.1% between 2023 and 2033, totaling around USD 8,770 million by 2033. The rising prevalence of various diseases across the world is a key factor driving demand for retractable needle safety syringes.
Manual retractable safety syringe is expected to continue to lead the global retractable needle safety syringes market based on product, accounting for around 62.13% share in 2022.
In 2022, the market value for retractable needle safety syringes market held more than 2.6% of the overall global medical supplies market which stood at around USD 215.0 billion.
The demand for retractable needle safety syringes is increasing constantly due to the rising incidence of needle stick injuries. All parenteral pharmaceutical products have to be injected using drug delivery devices. Also, syringes are the most commonly used devices. Injecting through needle-based devices presents a considerable risk of needle stick injury. For instance,
The Centers for Disease Control and Prevention reports that over 385,000 needle stick injuries affect healthcare professionals each year in the United States. In particular, blood-borne viruses are spreading through these needle stick injuries. Hepatitis B and hepatitis C are of concern, as well as the human immunodeficiency virus (HIV), which causes AIDS (acquired immune deficiency syndrome).
The rising number of needle stick injuries has resulted in a shift toward regulatory authorities recommending the use of protected needles and retractable needle safety syringes, which is helping to boost the global retractable needle safety syringes industry.
Companies operating in the retractable needle safety syringes industry are actively seeking to strengthen their position through product launches, approvals, collaborations, and partnerships with established as well as emerging market players. For instance,
| Attributes | Statistics |
|---|---|
| Retractable Needle Safety Syringes Market Base Value (2023) | USD 5,846.6 million |
| Projected Market Size (2033) | USD 8,770 million |
| Value-based CAGR (2023 to 2033) | 4.1% |
| Market Share of Top 5 Countries | 53.9% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global sales of retractable needle safety syringes are anticipated to rise at a CAGR of 4.1% between 2023 and 2033, owing to the increased adoption of advanced retractable needle safety syringes across healthcare facilities.
There has been an increasing adoption of manual retractable safety syringes, thereby making it the leading segment with the advantages of manual retractable safety syringes over other available syringes found in the market. Further, the demand for retractable needle safety syringes is rising due to a surge in diseases like diabetes, cancer, and hepatitis, growing health awareness among people, and innovations in retractable needle safety syringes.
Safety needles improve user convenience and practicability while lowering the risk of infection and cost. The majority of healthcare professionals prefer safety needle technology to conventional devices due to beneficial factors like accuracy, operation time, and fast usage design.
Retractable safety syringes increase the patient’s power in making healthcare decisions, which is eventually helping to boost the global market for retractable needle safety syringes.
In addition, many people use sterile needles and syringes for each injection for the administration of drugs.
Sterile needles prevent the spread of diseases like HIV and viral hepatitis among other infections. People who inject drugs have access to sterile needles and syringes through pharmacies and syringe services programs (SSPs) in several areas.
Access to syringes is also possible through a doctor’s prescription and through other healthcare services. SSPs are based on community programs that provide access to sterile syringes and needles at no cost and help in facilitating the safe disposal of used needles and syringes.
The increasing number of needle and syringe programs aimed at reducing the possibility of disease transmission is one of the primary factors contributing to the growth of the global retractable needle safety syringe industry.
Introduction of Stringent Regulations Pushing Demand for Retractable Needle Safety Syringes
The global sales of retractable needle safety syringes are expected to rise due to increasing government initiatives and regulations to maximize the use of safe syringes. Over the years, the rising incidence of needle stick injuries and the high mortality rate associated with these injuries have prompted governments and regulatory bodies to take various steps. To reduce needle stick injuries and prevent needle reusing, countries like Germany, the United States, and other ASEAN have passed legislation requiring the use of safe syringes.
Thanks to the introduction of this regulation, safety syringes such as retractable needle safety syringes are now used frequently compared to traditional syringes, which has resulted in a significant increase in demand in the market for retractable needle safety syringes.
Retractable needle safety syringes have an internal safety device and either a detachable or a fixed needle. Further, they help in avoiding accidental needle stick injuries among healthcare professionals and spreading blood-borne diseases.
Principal Consultant
The presence of alternative drug delivery solutions like needle-free injection technology is becoming a key factor restraining the growth of the retractable needle safety syringes industry.
The “needle-free injection technology" (NFIT) comprises a wide variety of drug delivery methods that administer medication through the skin using forces like Lorentz, shock waves, pressure from gases, or electrophoresis, all of which potentially reduce the need for retractable as well as hypodermic needles.
A Notable Rise in Needle Stick Injuries Pushing Demand for Retractable Needle Safety Syringes in the United States
| Country | The United States |
|---|---|
| Market Share % (2022) | 27.2% |
The United States held a total share of 81.4% of North America’s retractable needle safety syringes market in 2022 and is poised to exhibit steady growth during the forecast period. Growth in the United States retractable needle safety syringes market is driven by rising cases of needle stick injuries, increasing adoption of advanced technologies, and the presence of a well-established healthcare industry. Also, in recent years, there has been a sharp rise in needle stick injuries across the United States. For instance,
Rising investments and government support in conducting research in various sectors are expected to attract huge attention to the retractable needle safety syringes market in the United States.
Increasing Prevalence of Chronic Diseases Propelling Retractable Needle Safety Syringes Sales in Germany
| Country | Germany |
|---|---|
| Market Share % (2022) | 4.4% |
As per FMI, the retractable needle safety syringes industry in Germany is set to exhibit a CAGR of 4.1% during the forecast period. Demand for retractable needle safety syringes in Germany is driven by the increasing prevalence of chronic diseases.
According to the European Commission report of 2019, around 58 percent of Germans, 65 and older, suffered from at least one chronic illness in 2017, a percentage that is slightly higher than that of other European nations.
Retractable needle safety syringes are being preferred for administering medicines to treat various chronic diseases. This might continue to propel sales of retractable needle safety syringes in the country during the assessment period.
Increasing Healthcare Spending Favoring Market Growth in China
| Country | China |
|---|---|
| Forecast CAGR % (2023 to 2033) | 4.3% |
China held around 41.1% value share in the East Asia retractable needle safety syringes market in 2022 and is projected to expand at a steady pace. Moreover, this growth is associated with rising healthcare expenditure, a notably growing geriatric population, and significantly improving medical infrastructure.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Sales of Manual Retractable Safety Syringes to Outperform Automatic Ones
| Segment | Manual Retractable Safety Syringe |
|---|---|
| Market Share % (2022) | 62.13% |
Manual retractable safety syringes currently hold a market share of around 62.13% in the global retractable needle safety syringes industry and this trend is likely to continue during the forecast period. This can be attributed to the rising usage of manual retractable safety syringes across healthcare facilities.
After administering the injection, the user of a manual retractable safety syringe can retract the needle either before or after extracting it from the patient.
Intravenous Segment is to Contribute most to the Global Retractable Needle Safety Syringes Market
| Segment | Intravenous |
|---|---|
| Market Share % (2022) | 44.99% |
The intravenous segment held a revenue share of 44.99% of the global retractable needle safety syringes market in 2022 and it is poised to expand at a relatively higher CAGR during the forecast period.
The high market share is because, with intravenous (IV) injection, the medication penetrates the systemic circulation directly, avoiding the first-pass drug effect and producing an instantaneous drug effect.
The Majority of Retractable Needle Safety Syringe Sales Remain Concentrated in Hospitals
As per FMI, the hospitals segment leads the global retractable needle safety syringes market with around 38.7%. This is attributable to the rising number of patients seeking treatments in hospitals and the surge in hospital-acquired infections.
Today, majority of the hospitals use retractable needle safety syringes due to their safe and hygienic nature. Further, the adoption of these syringes helps hospitals to curb the transmission of diseases due to needle stick injuries.
End Users Prefer to Purchase Retractable Needle Safety Syringes through Direct to Customer Channel
The direct to customer distribution channel leads the retractable needle safety syringes market with around 89.3% market share. It is because the direct-to-consumer distribution channel involves selling goods directly to clients rather than through wholesalers, retailers, or other middlemen.
Key players in the retractable needle safety syringes market are continuously adopting various organic and inorganic strategies such as acquisitions, partnerships, mergers, new product launches, and geographical expansion to increase their revenue share and gain an upper hand in the market.
Given below are a few examples of the key strategies followed by the manufacturers:
New startups are entering the safety syringes business amid increasing opportunities in retractable needle safety syringes space. Also, they are embracing innovation to introduce novel products that could potentially eliminate the risk of needle stick injuries.
| Attributes | Details |
|---|---|
| Base Market Value (2022) | USD 5,846.6 million |
| Projected Market Size (2033) | USD 8,770.0 million |
| Growth Rate (2023 to 2033) | 4.1% |
| Forecast Period | 2018 to 2022 |
| Historical Data Available for | 2023 to 2033 |
| Market Analysis | USD million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | The United States, Canada, Brazil, Mexico, Argentina, Germany, The United Kingdom, France, Italy, Spain, BENELUX, Russia, Nordic Countries India, Indonesia, Malaysia, Philippines, Thailand, Vietnam, China, Japan, South Korea, Australia, New Zealand, GCC Countries, Turkey, Israel, North Africa, and South Africa |
| Key Market Segments Covered | Product, Application, End User, Distribution Channel, and Region |
| Key Companies Profiled |
Axel Bio Corporation, Inc; Becton, Dickinson, and Company; Numedico; Lifelong Group; DMC Medical Ltd.; Retractable Technologies, Inc.; Smiths Medical; Sol-Millennium Medical Group; UltiMed, Inc. (Ulticare); Revolutions Medical Corporation; Medicina (HMC Group); Haiou Medical; Mediprim; Cardinal Health; Medline Industries; Duopross Meditech Corp.; Nipro Corporation; Terumo Corporation |
| Pricing | Available upon Request |
The global market size is to reach USD 8,770 million by 2033.
Numedico, Lifelong Group, and DMC Medical Ltd. are key players in the market.
Key players are adopting various organic and inorganic strategies, such as acquisitions and partnerships.
The United States, Japan, and China dominate the global market.
Manual retractable safety syringes are the top-selling product in the market.
The United States held 81.4% of North America’s retractable needle safety syringes market 2022.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Manual Retractable Safety Syringe 5.2. Auto-retractable Safety Syringe 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Subcutaneous 6.2. Intramuscular 6.3. Intravenous 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User 7.1. Hospitals 7.2. Clinics 7.3. Ambulatory Surgical Centres 7.4. Others 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel 8.1. Direct to Customer 8.2. Retail 8.2.1. Retail Pharmacies 8.2.2. Drug Stores 8.3. Online Pharmacies 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. South Asia and Pacific 9.6. East Asia 9.7. Middle East and Africa 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 17. Key Countries Market Analysis 18. Market Structure Analysis 19. Competition Analysis 19.1. Axel Bio Corporation, Inc 19.2. Becton, Dickinson and Company 19.3. Numedico 19.4. Lifelong Group 19.5. DMC Medical Ltd. 19.6. Retractable Technologies, Inc. 19.7. UltiMed, Inc. (Ulticare) 19.8. Revolutions Medical Corporation 19.9. Medicina (HMC Group) 19.10. Haiou Medical 19.11. Mediprim 19.12. Cardinal Health 19.13. Medline Industries 19.14. Duopross Meditech Corp. 19.15. Nipro Corporation 19.16. Terumo Corporation 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
Retractable Needle Safety Syringes Market
